Jörg Knäblein

Scientific Finder Collaborate to Cure Hub EMEA at Bayer Pharmaceuticals

Speaker

Dr. Jörg Knäblein is currently Scientific Finder in the Collaborate to Cure Hub EMEA, the regional partnering interface of Bayer AG within Business Development & Licensing and Open Innovation. He is responsible for identification and evaluation of new technologies, projects, or molecules from external sources.

Prior, Jörg worked for more than 14 years as Technology Scout within Global External Innovation & Alliances inside Global Drug Discovery of Bayer and also headed Bayer´s CoLaborator Berlin, an incubator to host biotech startups.

Before he had several positions within the company, including Head of Microbiological Chemistry Department at former Schering AG and also worked for Schering’s biotech subsidiary Berlex Biosciences in San Francisco and for Hoechst in New Jersey (1995) and UK (1990).

Jörg holds two diploma, one in biotechnology from The Society of Biotechnology Research (GBF) and another in biochemistry from Max-Planck-Institute for Biochemistry. Here, he also received his PhD working with Prof. Robert Huber (Nobel Prize Laureate 1988).

After winning the First McKinsey Business Plan contest (1997), he founded the biotech company “Proteros” (with today more than 80 employees), prior to working for a HighTech consultancy firm for two years – focusing on the LifeScience business of global players (i.e. Baxter, Hoechst, Elan).

He serves as “Executive Board Member and Scientific Advisor to the European Association of Pharmaceutical Biotechnology” (EAPB), and to the Editorial Boards of the “Biotechnology Journal” (BTJ: BTJ) and the “European Journal of Pharmaceutics and Biopharmaceutics” (EJPB). Jörg is author and editor of the four-volume publication "Modern Biopharmaceuticals: Design, Development and Optimization" published at Wiley-VCH in 2005 and the sequel "Modern Biopharmaceuticals: Recent Success Stories" (2013).